These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 29497280)

  • 1. Short-term efficacy of intravitreal conbercept in treatment-naive patients with polypoidal choroidal vasculopathy.
    Peng Y; Zhang X; Li M; Liu B; Mi L; Zuo C; Wen F
    Drug Des Devel Ther; 2018; 12():339-345. PubMed ID: 29497280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of intravitreal injection of conbercept for the treatment of patients with choroidal neovascularization secondary to pathological myopia: Results from the SHINY study.
    Gao L; Song Y; Sun X; Zhang J; Liu Y; Chen Y; Wu Z; Jian Y; Liu X; Lv L; Chen S; Wang YS; Chen N; Ke X; Zhang F
    Acta Ophthalmol; 2024 Jun; 102(4):e577-e586. PubMed ID: 38009430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHORT-TERM EFFICACY OF CONBERCEPT AND RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Huang Z; Ding Q; Yan M; Lian H; Chen Z; Chen X; Song Y
    Retina; 2019 May; 39(5):889-895. PubMed ID: 29360683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One-year results of intravitreal conbercept in treatment-naïve subjects with polypoidal choroidal vasculopathy.
    Ye LH; Cai Y; Shi X; Wong IYH; Qu JF; Zhao MW; Ying X; Li XX
    Graefes Arch Clin Exp Ophthalmol; 2021 Jun; 259(6):1455-1462. PubMed ID: 33146832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of conbercept as a primary treatment for choroidal neovascularization secondary to punctate inner choroidopathy.
    Peng Y; Zhang X; Mi L; Liu B; Zuo C; Li M; Wen F
    BMC Ophthalmol; 2017 Jun; 17(1):87. PubMed ID: 28606070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY: As Needed Versus Fixed Interval Dosing.
    Inoue M; Yamane S; Taoka R; Arakawa A; Kadonosono K
    Retina; 2016 Aug; 36(8):1527-34. PubMed ID: 26710307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term efficacy of intravitreal aflibercept for patients with treatment-naïve polypoidal choroidal vasculopathy.
    Ijiri S; Sugiyama K
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):351-7. PubMed ID: 25023147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Subgroup Analysis of the Aurora Study.
    Qu J; Cheng Y; Li X; Yu L; Ke X;
    Retina; 2016 May; 36(5):926-37. PubMed ID: 26595362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-Year Results of Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy.
    Yamamoto A; Okada AA; Kano M; Koizumi H; Saito M; Maruko I; Sekiryu T; Iida T
    Ophthalmology; 2015 Sep; 122(9):1866-72. PubMed ID: 26088619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Brolucizumab in Polyp Regression of Treatment-Naive Polypoidal Choroidal Vasculopathy and Its Effect on 1-Year Treatment Outcome.
    Lee SH; Park HS; Han JW
    Korean J Ophthalmol; 2024 Jun; 38(3):185-193. PubMed ID: 38584441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INTRAVITREAL INJECTION OF AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A 3-YEAR FOLLOW-UP.
    Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
    Retina; 2018 Oct; 38(10):2001-2009. PubMed ID: 28816730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subfoveal choroidal thickness in polypoidal choroidal vasculopathy after switching to intravitreal aflibercept injection.
    Saito M; Kano M; Itagaki K; Ise S; Imaizumi K; Sekiryu T
    Jpn J Ophthalmol; 2016 Jan; 60(1):35-41. PubMed ID: 26350229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Efficacy of Three Loading Doses of Intravitreal Injection of Conbercept with Injection Combined with PDT for the Treatment of PCV.
    Li F; Ma A; Zhao B
    Biomed Res Int; 2020; 2020():2428348. PubMed ID: 32382537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of polypoidal lesion-selective photodynamic therapy with intravitreal antivascular endothelial growth factor for polypoidal choroidal vasculopathy.
    Komuku Y; Iwahashi C; Gomi F
    Jpn J Ophthalmol; 2020 May; 64(3):265-270. PubMed ID: 32206935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Six-month results of intravitreal aflibercept injections for patients with polypoidal choroidal vasculopathy.
    Hosokawa M; Shiraga F; Yamashita A; Shiragami C; Ono A; Shirakata Y; Kimura S; Shiode Y; Kawata T; Hosogi M; Fujiwara A; Morizane Y
    Br J Ophthalmol; 2015 Aug; 99(8):1087-91. PubMed ID: 25712826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined photodynamic therapy with intravitreal bevacizumab injections for polypoidal choroidal vasculopathy: long-term visual outcome.
    Kang HM; Koh HJ; Lee CS; Lee SC
    Am J Ophthalmol; 2014 Mar; 157(3):598-606.e1. PubMed ID: 24269378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.
    Chaikitmongkol V; Upaphong P; Patikulsila D; Jirarattanasopa P; Choovuthayakorn J; Watanachai N; Kunavisarut P; Ratanasukon M; Bhurayanontachai P; Ingviya T; Bressler SB; Bressler NM
    Ophthalmol Retina; 2022 Jan; 6(1):21-28. PubMed ID: 33781929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for exudative branching vascular networks in polypoidal choroidal vasculopathy.
    Wakabayashi T; Gomi F; Sawa M; Tsujikawa M; Nishida K
    Br J Ophthalmol; 2012 Mar; 96(3):394-9. PubMed ID: 21719568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aflibercept therapy for polypoidal choroidal vasculopathy: short-term results of a multicentre study.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Br J Ophthalmol; 2015 Sep; 99(9):1284-8. PubMed ID: 25777816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.